JCR Pharmaceuticals Co Eulerpool Новини

JCR Pharmaceuticals Co Eulerpool News

JCR Pharmaceuticals Co Новини за акции

JCR Pharmaceuticals Co се наблюдава от множество журналисти и инвеститори по целия свят. Най-актуалните JCR Pharmaceuticals Co новини събираме тук.

• 19 март ·

  Yahoo
  JCR Pharmaceuticals Announces Achievement of Milestone Using J-Brain Cargo® Technology for Neurodegenerative Disease in Research Collaboration with Alexion
• 29 февруари ·

  Yahoo
  JCR Pharmaceuticals Celebrates Rare Disease Day 2024 and Highlights Its Commitment to the Rare Disease Community
• 14 февруари ·

  Yahoo
  JCR Pharmaceuticals’ Research Presentations at WORLDSymposium™ 2024 Showcase JR-141 (Pabinafusp Alfa) and Other Investigational Treatments for Lysosomal Storage Disorders
• 25 януари ·

  Yahoo
  JCR Pharmaceuticals to Present at the 20th Annual WORLDSymposium™ 2024
• 21 декември ·

  Yahoo
  JCR Pharmaceuticals and Takeda Pharmaceuticals Announce Discontinuation of Gene Therapy Collaboration
• 21 декември ·

  Yahoo
  JCR Announces Research Collaboration, Option and License Agreement with Alexion on Discovery of Oligonucleotide Therapeutics Using J-Brain Cargo® Technology
• 15 декември ·

  Yahoo
  U.S. FDA Grants Orphan Drug Designation to JR-441 for the Treatment of Mucopolysaccharidosis Type IIIA (MPS IIIA)
• 10 ноември ·

  Yahoo
  JCR Pharmaceuticals Announces First Patient Dosed in a Global Phase I/II Clinical Trial of JR-441 for the Treatment of MPS IIIA
• 29 септември ·

  Yahoo
  JCR Pharmaceuticals Announces 52-Week Interim Data from its Global Phase I/II Study of JR-171 in Individuals with Mucopolysaccharidosis Type I (MPS I)
• 11 май ·

  Yahoo
  Angelini Pharma and JCR Pharmaceuticals Announce Global Collaboration for the Development and Commercialization of Novel Biologic Therapies in Epilepsy